Brown, Mary N. http://orcid.org/0000-0002-2343-8756
Fuhr, Rainard
Beier, Jutta
Su, Hong-Lin
Chen, Yingxue
Forsman, Henrik
Hamrén, Ulrika Wählby
Jackson, Helen
Aggarwal, Ajay
Funding for this research was provided by:
AstraZeneca (Not applicable)
Article History
Received: 15 October 2018
Accepted: 5 February 2019
First Online: 18 February 2019
Ethics approval and consent to participate
: The study protocol was approved by the Institutional Review Board (IRB) or Independent Ethics Committee (IEC) at each center. The study (NCT02479412) was done in accordance with the Declaration of Helsinki, the International Council of Harmonisation guidelines for good clinical practice, and applicable regulatory requirements. All patients provided written informed consent before being enrolled in the study.
: Not applicable.
: MB, YC, HF, UWH are current employees of AstraZeneca, AA and HS are former employees of AstraZeneca and own stock, and HJ is a former employee of AstraZeneca and does not own stock. JB has received consultancy and speaking fees from AstraZeneca RF is an employee of PAREXEL. AstraZeneca provided funding to PAREXEL for the conduct of this study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.